Pages that link to "Q38881940"
Jump to navigation
Jump to search
The following pages link to Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial (Q38881940):
Displaying 19 items.
- Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan (Q24814441) (← links)
- A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women (Q28469347) (← links)
- An economic evaluation of home management of malaria in Uganda: an interactive Markov model (Q28475337) (← links)
- Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières (Q33358271) (← links)
- Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon (Q33611095) (← links)
- Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial (Q34413590) (← links)
- Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda (Q34983307) (← links)
- Assessment of safety of the major antimalarial drugs (Q36945007) (← links)
- Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial (Q37182225) (← links)
- Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central Afri (Q37525389) (← links)
- Plasmodium falciparum gametocytes: with a view to a kill. (Q38129536) (← links)
- Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness (Q39278723) (← links)
- Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations (Q40509311) (← links)
- Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali (Q41945132) (← links)
- Intermittent preventive treatment of malaria in infancy (Q43274378) (← links)
- Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered (Q43946037) (← links)
- Artemisinin combination therapies and malaria parasite drug resistance: the game is afoot (Q47859200) (← links)
- Effectiveness of ACTs in cases of resistance to partner drugs (Q47983515) (← links)
- Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug! (Q64232067) (← links)